Author

Kanchan Kohli

Jamia Hamdard, New Delhi-110062 - Cited by 9,778 - Formulation Development

Biography

Dr. Kanchan Kohli  is currently working at Pharmaceutical Department. Kanchan Kohli  is research interests includes Pharmaceutical in Broccoli sprouts. Kanchan Kohli  serving as an editorial member and reviewer of several international reputed journals. Kanchan Kohli has successfully completed his Administrative responsibilities. Kanchan Kohli  has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials
B Mangla, S Javed, MH Sultan, P Kumar, K Kohli, A Najmi, HA Alhazmi, ...Phytotherapy Research 35 (10), 5440-5458, 2021202
38
2021
Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment
NK Soni, LJ Sonali, A Singh, B Mangla, YR Neupane, K KohliNanotechnology 31 (47), 475101, 2020202
28
2020
Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo, in vivo and toxicity studies
B Mangla, YR Neupane, A Singh, P Kumar, S Shafi, K KohliNanomedicine 15 (), 2563-2583, 2020202
26
2020
Formulation design and evaluation of aceclofenac nanogel for topical application
MS Alam, MS Algahtani, J Ahmad, K Kohli, S Shafiq-un-Nabi, MH Warsi, ...Therapeutic Delivery 11 (12), 767-778, 2020202
19
2020
Systematic development and validation of RP-HPLC method for simultaneous estimation of tamoxifen and sulphoraphane with specific application for nanolipidic formulations
B Mangla, S Beg, O Alam, W Ahsan, A Haque, KS Patel, WH Almalki, ...Arabian Journal of Chemistry 13 (11), 7909-7920, 2020202
18
2020
Amelioration of endotoxin-induced uveitis in rabbit by topical administration of tacrolimus proglycosome nano-vesicles
V Garg, J Nirmal, Y Riadi, P Kesharwani, K Kohli, GK JainJournal of Pharmaceutical Sciences 110 (2), 871-875, 2021202
17
2021
Development of natural polysaccharide–based nanoparticles of berberine to enhance oral bioavailability: Formulation, optimization, ex vivo, and in vivo assessment
K Kohli, A Mujtaba, R Malik, S Amin, MS Alam, A Ali, MA Barkat, MJ AnsariPolymers 13 (21), 3833, 2021202
16
2021
Nanotechnology based approach for hepatocellular carcinoma targeting
A Alhalmi, S Beg, K Kohli, M Waris, T SinghCurrent Drug Targets 22 (7), 779-792, 2021202
15
2021
Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid)(PLGA) nanoparticles for potential treatment of age-related macular degeneration
R Suri, YR Neupane, N Mehra, M Nematullah, F Khan, O Alam, A Iqubal, ...International journal of biological macromolecules 191, 548-559, 2021202
14
2021
Recent advances in targeted nanotherapeutic approaches for breast cancer management
P Gupta, YR Neupane, S Parvez, K KohliNanomedicine 16 (29), 2605-2631, 2021202
10
2021
Recent theranostic paradigms for the management of Age-related macular degeneration
R Suri, YR Neupane, GK Jain, K KohliEuropean Journal of Pharmaceutical Sciences 153, 5489, 2020202
10
2020
Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an …
B Mangla, O Alam, RA Rub, M Iqbal, A Singh, KS Patel, K KohliJournal of Chromatography B 1152, 122260, 2020202
9
2020
Nanostructured lipid carrier-based codelivery of raloxifene and naringin: Formulation, optimization, in vitro, ex vivo, in vivo assessment, and acute toxicity studies
A Alhalmi, S Amin, Z Khan, S Beg, O Al Kamaly, A Saleh, K KohliPharmaceutics 14 (), 1771, 2022202
9
2022
Nanoemulsion system for improvement of raspberry ketone oral bioavailability
S Singh, T Virmani, K KohliIndo Glob. J. Pharm. Sci 10 (01), 33-42, 2020202
8
2020
Gut microbiota as an emerging therapeutic avenue for the treatment of nonalcoholic fatty liver disease
T Ralli, YR Neupane, Z Saifi, K KohliCurrent Pharmaceutical Design 2 (46), 46-4685, 2021202
7
2021
Exploration of a transdermal nanoemulgel as an alternative therapy for postmenopausal osteoporosis
F Zakir, A Ahmad, MA Mirza, K Kohli, FJ AhmadJournal of Drug Delivery Science and Technology 65, 10245, 2021202
7
2021
PEGylated nanoliposomes potentiated oral combination therapy for effective cancer treatment
A Singh, YR Neupane, B Mangla, S Shafi, K KohliCurrent Drug Delivery 1 (9), 28-35, 2020202
7
2020
Menopausal remediation and quality of life (QoL) improvement: insights and perspectives
S Mohapatra, Z Iqbal, S Ahmad, K Kohli, U Farooq, S Padhi, M Kabir, ...Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2020202
7
2020
Nanocarriers-assisted needle-free vaccine delivery through oral and intranasal transmucosal routes: A novel therapeutic conduit
B Mangla, S Javed, MH Sultan, W Ahsan, G Aggarwal, K KohliFrontiers in pharmacology 12, 77761, 2022202
5
2022
Folic acid engineered sulforaphane loaded microbeads for targeting breast cancer
Z Khan, A Alhalmi, N Tyagi, WU Khan, A Sheikh, MAS Abourehab, K Kohli, ...Journal of Biomaterials Science, Polymer Edition 34 (), 674-694, 2023202
5
2023

Referred From: https://scholar.google.co.in/citations?user=HBxCyQYAAAAJ&hl=en

Cited by
Citations 9778
h-index 47
i10-index 147
Recommended Journals
Open Access Journals